Lookup NU author(s): Dr David Owen,
Dr Ana Topf,
Dr Teresinha Evangelista,
Professor Hanns Lochmuller
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
© 2018 Wiley Periodicals, Inc.Congenital myasthenic syndrome (CMS) is a heterogeneous disorder that causes fatigable muscle weakness. CMS has been associated with variants in the MuSK gene and, to date, 16 patients have been reported. MuSK-CMS patients present a different phenotypic pattern of limb girdle weakness. Here, we describe four additional patients and discuss the phenotypic and clinical relationship with those previously reported. Two novel damaging missense variants are described: c.1742T > A; p.I581N found in homozygosis, and c.1634T > C; p.L545P found in compound heterozygosis with p.R166*. The reported patients had predominant limb girdle weakness with symptom onset at 12, 17, 18, and 30 years of age, and the majority exhibited a good clinical response to Salbutamol therapy, but not to esterase inhibitors. Meta-analysis including previously reported variants revealed an increased likelihood of a severe, respiratory phenotype with null alleles. Missense variants exclusively affecting the kinase domain, but not the catalytic site, are associated with late onset. These data refine the phenotype associated with MuSK-related CMS.
Author(s): Owen D, Topf A, Preethish-Kumar V, Lorenzoni PJ, Vroling B, Scola RH, Dias-Tosta E, Geraldo A, Polavarapu K, Nashi S, Cox D, Evangelista T, Dawson J, Thompson R, Senderek J, Laurie S, Beltran S, Gut M, Gut I, Nalini A, Lochmuller H
Publication type: Article
Publication status: Published
Journal: American Journal of Medical Genetics, Part A
Print publication date: 16/07/2018
Online publication date: 28/04/2018
Acceptance date: 20/03/2018
ISSN (print): 1552-4825
ISSN (electronic): 1552-4833
Publisher: Wiley-Liss Inc.
PubMed id: 29704306
Altmetrics provided by Altmetric